Column Group IV GP, LP is Director & 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 4 open-market trades across 2 companies since 2022, most recently 2026-09-03.
CIK 0001796356
4 open-market purchases totalling $39.9M since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EIKN | 89,200 | $663K |
| NGM | 90,442 | $139K |
| Total | $802K |
Shares reported on the most recent Form 4, priced at the 2026-09-08 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.